dc.contributor.author | Yang, Yu Chi | |
dc.contributor.author | Banuelos, Carmen Adriana | |
dc.contributor.author | Mawji, Nasrin R | |
dc.contributor.author | Wang, Jun | |
dc.contributor.author | Kato, Minoru | |
dc.contributor.author | Haile, Simon | |
dc.contributor.author | McEwan, Iain J | |
dc.contributor.author | Plymate, Stephen | |
dc.contributor.author | Sadar, Marianne D | |
dc.date.accessioned | 2017-05-02T23:01:33Z | |
dc.date.available | 2017-05-02T23:01:33Z | |
dc.date.issued | 2016-09-01 | |
dc.identifier.citation | Yang , Y C , Banuelos , C A , Mawji , N R , Wang , J , Kato , M , Haile , S , McEwan , I J , Plymate , S & Sadar , M D 2016 , ' Targeting androgen receptor activation function-1 with EPI to overcome resistance mechanisms in castration-resistant prostate cancer ' , Clinical Cancer Research , vol. 22 , no. 17 , pp. 4466–4477 . https://doi.org/10.1158/1078-0432.CCR-15-2901 | en |
dc.identifier.issn | 1078-0432 | |
dc.identifier.other | PURE: 65918540 | |
dc.identifier.other | PURE UUID: 3712c05c-8129-47e7-95ea-db55a4a528b8 | |
dc.identifier.other | Scopus: 84988654939 | |
dc.identifier.uri | http://hdl.handle.net/2164/8599 | |
dc.description | Acknowledgments The authors thank Kate Watt (University of Aberdeen, Aberdeen, Scotland) for technical support. The authors are also grateful to Country Meadows Senior Men's Golf Charity Classic for financial support of this research. Financial support: This research was supported by grants to MDS from the NCI (2R01CA105304), the Canadian Institutes of Health Research (MOP79308) and the US Army Medical Research and Materiel Command Prostate Cancer Research Program (E81XWH-11-1-0551). Research by IJM’s group was supported by the Chief Scientist’s Office of the Scottish Government (ETM-258 and -382). We are grateful to Country Meadows Senior Men’s Golf Charity Classic for financial support of this research. | en |
dc.format.extent | 12 | |
dc.language.iso | eng | |
dc.relation.ispartof | Clinical Cancer Research | en |
dc.rights | © 2016 American Association for Cancer Research. | en |
dc.subject | SDG 3 - Good Health and Well-being | en |
dc.subject | androgen receptor | en |
dc.subject | N-terminal domain | en |
dc.subject | EPI | en |
dc.subject | castration-resistant prostate cancer | en |
dc.subject | resistance mechanisms | en |
dc.subject | RC0254 Neoplasms. Tumors. Oncology (including Cancer) | en |
dc.subject | Chief Scientist Office (CSO) | en |
dc.subject | ETM-258 | en |
dc.subject | ETM-382 | en |
dc.subject | Supplementary Data | en |
dc.subject.lcc | RC0254 | en |
dc.title | Targeting androgen receptor activation function-1 with EPI to overcome resistance mechanisms in castration-resistant prostate cancer | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Medical Sciences | en |
dc.contributor.institution | University of Aberdeen.Institute of Medical Sciences | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Postprint | en |
dc.identifier.doi | https://doi.org/10.1158/1078-0432.CCR-15-2901 | |
dc.date.embargoedUntil | 2017-05-02 | |
dc.identifier.vol | 22 | en |
dc.identifier.iss | 17 | en |